How the human immune system resets after Staph infection

Staph Infection on face

When pathogenic bacteria like Salmonella or Staphylococcus invade our bodies, we go into a state of high alert and alter our metabolism to defend against the attack.

Yet sometimes that war doesn’t stop and we stay on immunological high alert, wasting energy on an attack that isn’t there rather than repairing the damage done by bacterial invaders.

Researchers have uncovered the genes that should normally be activated during recovery from bacterial infection. By finding ways to “jumpstart” the recovery process it may be possible to fend off autoimmune diseases and chronic inflammatory disorders that can result from the body staying in attack mode for too long.

C. elegans

Duke researchers have uncovered the genes that are normally activated during recovery from bacterial infection in the C. elegans worm. The finding could be key to new antibiotics and countering auto-immune disorders. Credit: Duke University, Alejandro Aballay

“While the steps involved in recognizing microbial pathogens and inducing the immune response have been extensively studied, the pathways involved in host recovery after an infection are not well understood,” said Alejandro Aballay, Ph.D., an associate professor of molecular genetics and microbiology at Duke University School of Medicine.

To examine the biological changes associated with this transition from wartime to peacetime, Aballay and lead study author Brian Heard, PhD, a postdoctoral fellow in his lab, infected the worm C. elegans with the common bacterial pathogen Salmonella enterica.

The researchers used gene chip technology to identify genes in the worm that were “turned off” or “turned on” during that initial infection. Then they treated the worm with the antibiotic tetracycline and looked to see what genes were dampened or activated as the organism recovered from infection.

They discovered that as the infection resolves, genes involved with stimulating the immune response were turned off, while genes involved in returning to business as usual — a process known as “cellular homeostasis” – were turned on. These recovery genes play important roles in repairing tissue damage, eliminating bacterial toxins and clearing the cellular fighters that could cause excessive inflammation and further harm tissues.

When the researchers looked closer at the genes involved in recovery, they discovered many were controlled by the ELT-2 transcription factor, a type of master switch that had already been shown to regulate when and where immune response genes were expressed. The researchers showed that shutting down this master switch prevented infected animals from recovering with antibiotic treatment, showing that ELT-2 functions not only in defense but also in recovery.

“Our studies indicate that host or bacterial signals during the initial decline in infection may shift ELT-2’s duties from priming the innate immune to protecting against chemical insults,” Aballay said. “This opens a number of possibilities for further research.”

Aballay says a number of studies in C. elegans have shown that the worm’s nervous system, which can respond rapidly to all sorts of environmental stimuli, is ultimately responsible for activating the immune system in response to bacterial infection. So now he plans to conduct experiments in the worm to determine whether the nervous system also controls the recovery after infections have been cleared.

This is from a news release

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion more—to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-02-20-at-10.48.04-AM
Deepfakes raise profound ethical questions in science
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.